LINCOLN Pharmaceuticals | LINCOPH | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Cash and cash equiva... |
| 116 | 146 | 55 | 146 | 138 |
Short-term investment |
| 102 | 0 | 181 | 342 | 807 |
Accounts receivables |
| 913 | 1,094 | 1,225 | 1,013 | 1,113 |
Inventories |
| 373 | 454 | 362 | 474 | 466 |
Deferred income taxes |
| 0 | 0 | 0 | 0.01 | 0 |
Other current assets |
| 215 | 379 | 386 | 505 | 540 |
Total current assets |
| 1,719 | 2,074 | 2,208 | 2,480 | 3,065 |
Gross property plant... |
| 935 | 1,070 | 1,134 | 1,128 | 1,100 |
Accumulated Depriciat... |
| 0 | 0 | 0 | 0 | 0 |
Net property, plant and Eq... |
| 935 | 1,070 | 1,134 | 1,128 | 1,100 |
Work in Progress |
| 66 | 3 | 0 | 0.4 | 17 |
Miscellaneous Investment |
| 252 | 201 | 0 | 149 | 252 |
Deferred income taxes |
| 0 | 0 | 0 | 0 | 0 |
Intangible assets |
| 96 | 3 | 4 | 4 | 4 |
Goodwill |
| 0 | 92 | 92 | 92 | 92 |
Other long-term assets |
| 0 | 29 | 214 | 41 | 65 |
Total non-current assets |
| 1,349 | 1,399 | 1,444 | 1,414 | 1,529 |
Total assets |
| 3,068 | 3,472 | 3,652 | 3,894 | 4,594 |
Short-term debt |
| 460 | 485 | 319 | 38 | 0 |
Accounts Payable... |
| 270 | 435 | 433 | 512 | 568 |
Provisions |
| 0.44 | 0.33 | 0 | 4 | 2 |
Taxes Payable |
| 0 | 18 | 1 | 9 | 32 |
Deferred Revenues |
| 0 | 0 | 0 | 0 | 0 |
Capital Leases |
| 0 | 0 | 0 | 0 | 0 |
Other current liabilities |
| 131 | 110 | 93 | 91 | 134 |
Total current liabilities |
| 862 | 1,049 | 846 | 656 | 735 |
Long-term debt |
| 177 | 69 | 17 | 8 | 1 |
Investments Liabilities |
| 0 | 0 | 0 | 0 | 0 |
Deferred tax liabilities |
| 90 | 72 | 56 | 54 | 57 |
Provisions |
| 0 | 0 | 0 | 0 | 0 |
Capital Leases |
| 0 | 0 | 0 | 0 | 0 |
Other longterm liabilities |
| 35 | 36 | 37 | 41 | 43 |
Total non-current liabilities |
| 301 | 178 | 109 | 103 | 101 |
Total liabilities |
| 1,163 | 1,227 | 955 | 759 | 837 |
Share Capital |
| 200 | 200 | 200 | 200 | 200 |
Share premium |
| 0 | 0 | 646 | 0 | 0 |
Retained earnings |
| 1,703 | 2,042 | 1,765 | 2,931 | 3,553 |
Accumulated other equity |
| 0 | 0 | 82 | 0 | 0 |
Preferred Stock |
| 0 | 0 | 0 | 0 | 0 |
Minority Interest |
| 2 | 3 | 4 | 4 | 4 |
Total Equity |
| 1,905 | 2,245 | 2,697 | 3,135 | 3,757 |
Total Liabilities and Equity |
| 3,068 | 3,472 | 3,652 | 3,894 | 4,594 |
Cash per Share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
Cash, Current Inv Per share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |